PREGNANCY AND HYPERTENSION: APPROACHES TO PATHOGENIC MECHANISMS OF FUNCTIONAL RESERVES SUPPORT OF UTEROPLACENTAL HEMODYNAMICS SYSTEM ( LITERATURE REVIEW).
DOI:
https://doi.org/10.11603/24116-4944.2014.2.6501Keywords:
arterial hypertension, uterine-placental hemodynamics, endothelial dysfunction.Abstract
The review systematizes and analyzes the main causes of disorders of the central and uteroplacental hemodynamics in pregnant women with hypertension, including the role of endothelial dysfunction. The global experience of the central and uterine-placental hemodynamics disorders correction is collected andevaluated according to the needs of today's.
References
Bukhonkyna YU.M., Stryuk R.Y. Yzmenenye plodovoplatsentarno-matochnoho krovotoka u beremennykh s artery-
alʹnoy hypertenzyey, varyanty korrektsyy. XVII Rossyyskyy natsyonalʹnyy konhress «Chelovek y lekarstvo». //
Sbornyk materyalov konhressa. Moskva, 12-16 aprelya 2010 h. - S. 59-60.
Ventskovskyy B.M., Vytovskyy YA.M. Yntensyvnoe nablyudenye y lechenye pry pozdnem hestoze: Noveyshyy medytsynskyy spravochnyk // Akusherstvo y hynekolohyya. Neotlozhnaya pomoshchʹ. — M.: Éksmo, 2008. — Hlava 4. — S. 51-83.
Vereyna N.K., Chulkov V.S., Synytsyn S.P., Korobeynykova É.N. Vzaymosvyazʹ konechnykh metabolytov oksyda azota y polymorfyzma T-786S promotora hena NO-syntetazy s oslozhnennym techenyem beremennosty u zhenshchyn pry arteryalʹnoy hypertenzyy // Vrach-aspyrant. - 2011 - №3 (46). - S. 316 -320.
Hipertenzyvni rozlady pid chas vahitnosti / Pro zatverdzhennya klinichnykh protokoliv z akushersʹkoyi ta hinekolohichnoyi dopomohy. // Nakaz MOZ Ukrayiny № 676 vid 12.2004. — K., 2004. — S. 4-31.
Heryak S. M., Hloba T. M., Kuziv I. YA. Akushersʹke znachennya kardialʹnykh ta metabolichnykh faktoriv ryzyku u va-
hitnykh iz arterialʹnoyu hipertenziyeyu // Medsestrynstvo. - 2013. - N 3. - S. 4-6
Hryshchenko V.Y., Kuzʹmyna Y.YU., Pasyeshvyly N.M., Teoretycheskye y praktycheskye aspekty razvytyya arteryalʹnoy hypertenzyy pry beremennosty // Medytsynskye aspekty zdorovʹya zhenshchyny. - 2010. -7 (35). - S. 17-24
Hurʹeva V.M., Petrukhyn V.A., Mravyan S.R., Kotov YU.B. Optymyzatsyya antyhypertenzyvnoy terapyy u beremennykh s pomoshchʹyu sutochnoho monytoryrovanyya arteryalʹnoho davlenyya // Klynycheskaya medytsyna. - 2008. - T.86. - №1. - S. 62-66.
Davydova Y.V. Tsentralʹnye sympatolytyky v lechenyy arteryalʹnoy hypertenzyy: nerealyzovannye podkhody k prymenenyyu. //Arteryalʹnaya hypertenzyya. - 4(18). - 2011. - S. 43-50.
Zaporozhan V.M., Tsehelʹsʹkyy M.R., Rozhkovsʹka N.M. Akusherstvo i hinekolohiya. Pidruchnyku 2-kh tomakh. T. 1. — Odesa: Odes. derzh. med. un_t, 2005. — 472 s.
Kaminsʹkyy V.V. Problemy materynsʹkoyismertnosti v Ukrayini: ekstrahenitalʹna patolohiya yak klyuchovyy element dlya znyzhennya materynsʹkoyismertnosti // Materialy III Vse ukrayinsʹkoyi naukovo-praktychnoyi konferentsiyi «Vnutrishnya patolohiya v akusherstvi ta hinekolohiyi» — Ternopilʹ. — 2013. — S. 3-5.
Lubyanaya S.S., Stryzhakova Y.V. y.dr. Novyy podkhodk terapyy platsentarnoy dysfunktsyy s yspolʹzovanyem L-arhynyna. // Zdorovʹe zhenshchyny. - 2010. - №8 (54). S 27-30.
Makarov O.V. Nykolaev N.N., Volkova E.V. Artery-alʹnaya hypertenzyya u beremennykh. Tolʹko ly hestoz? - M.:Héotar-Medya, 2006.- 176s.
Markov KH.M. Éndohennye ynhybytory oksyda azota y ykh znachenye v patolohyy // Rossyyskyy pedyatrycheskyy zhurnal. 2005. -№6.-S. 31-35.
Medvedʹ V.I. Vybrani lektsiyiz ekstrahenitalʹnoyi patolohiyi vahitnykh/ Medvedʹ V.I. - K., 2010. - 240 s.
Mykrotsyrkulyatsyya v kardyolohyy / Pod red. V.Y. Makolkyna. - M.: Vyzart, 2004. - 135 s.
Mynyrtychev K. D., Dyn Kym En Otsenka éffektyvnosty tyvortyna v kompleksnoy terapyy zaderzhky vnutryutrobnoho razvytyya ploda //Ukrayinsʹkyy khimioterapevtychnyy zhurnal - №3 (26) - 2012. - S.147-150.
Nebyerydze D.V. Dysfunktsyy éndotelyya y ee korrektsyy pry arteryalʹnoy hypertonyy // Russkyy medytsynskyy zhurnal. - 2006.-T. 14, №2.-S. 127-131.
Pokrovskyy V.Y., Vynohradov N.A. Oksyd azota, eho fyzyolohycheskye y patofyzyolohycheskye svoystva //Terapevtycheskyy arkhyv. - 2005. - №1. - S. 82-87.
Prystrom A.M. Arteryalʹnaya hypertenzyya beremennykh: dyahnostyka, klassyfykatsyya, klynycheskye formy: uchebnoe posobye. - Mynsk, 2011. - 103 s.
Rasulʹ-Zade YU.H., Klymashkyn A.A., Nazarov B.B. K voprosu o roly donatorov oksyda azota pry razlychnykh akusherskykh sostoyanyyakh // Ukrayinsʹkyy khimioterapevtychnyy zhurnal - № 3 (27) - 2012. - S. 108-111.
Ratsyonalʹnaya farmakoterapyya v akusherstve y hynekolohyy: Ruk. dlya praktykuyushchykh vrachey / V.Y. Kulakov, V.N. Serov, P.R. Abakarova y dr. -M.: Lytera. - 2006. - 1152 s.
Rekomendatsyy 2012 hoda po lechenyyu arteryalʹnoy hypertonyy // Ratsyonalʹnaya Farmakoterapyya v Kardyolohyy. — 2012. - 92 s.
Sydorova Y.S. Halynova Y.L. Éndotelyalʹnaya dysfunktsyya v razvytyy hestoza // Voprosy hynekolohyy, akusherstva y perynatolohyy. - 2006. - T.5, №1. - S. 75-81.
Stryuk R.Y., Bukhonkyna YU. M., Smyrnova V.A., Chyzhova H.V. Funktsyya éndotelyya y matochno-plodovo-platsentarnyy krovotoku beremennykh s arteryalʹnoy hypertonyey. // Kardyolohyya. - 2010. - №4. - S. 18-22.
Sukhykh H.T., Vykhlyaeva E.M., Vanʹke L.V., Khodzhaeva Z.S. y soavt. Éndotelyalʹnaya dysfunktsyya v heneze perynatalʹnoy patolohyy //Akusherstvo y hynekolohyya. - 2008. - № 5. - S. 3-7.
Shekhtman M.M. Hypertonycheskaya boleznʹ y beremennostʹ / M.M. Shekhtman, O.V. Kozynova // Hynekolohyya. 2005. - Tom 7, №5. - S. 307-310.
Baylis S. Nitric oxide deficiency in chronic kidney disease. //Am. J. Physiol. Renal Physiol. 2008; 294: 1-9.
Briasoulis A, Tousoulis D, Androulakis ES, Papageorgiou N, Latsios G, Stefanadis S. Endothelial dysfunction and atherosclerosis:
focus on novel therapeutic approaches. Review. Recent Pat. Cardiovasc Drug Discov. - 2012. - Apr; 7(1) - P. 21 -32.
Buger RH. The pharmacodynamics of L-arginine. // J. Nutr. - 2007; - 137: 1650S-1655S.
Bryan N.S., Bian K., Murad F. Discovery of the nitric oxide signaling pathway and targets for drug development. //
Frontiers in Bioscience. - 14: 2009. - P. 1-18.
Carlberg B, Samuelsson O, Lindholm LH. Atenolol in hypertension: is it a wise chouse? // Lancet. - 2004; - 364: 1684-9.
Challis, E.; Byrne, S.; Williams, J.L.R.; Pringle, J.H.; Hennessy, J.M. A Mosaic Cell Layer in Human Pregnancy. // Ockleford, C.D. Placenta vol. 31 issue. - 5 May, 2010. - P. 373-379
DeGracia P.V., Rueda C.M., Smith A. Pregnancy and Severe Chronic Hypertension in Pregnancy. // Hypertens Pregnancy/ — 2004. — Vol. 23, № 3. — P. 121-123.
Facchinetti F., Saade GH., Neri I., et al. L-arginine supplementation in patients with gestational hypertension: a pilotstudy. // Hypertens Pregnancy. - 26 (1). - 2007. - P. 121-130.
Fratta Passini A, Garbin U, Nava MC et al. Nebivolol decreases oxidative stress in essential hypertensive patients and increases nitric oxide by reducing its oxidative inactivation. / / J Hypertens . - 23 (3). - 2005. -P. 589-96.
Furchgott R.F. Vanhoutte P.M. Endothelium-derived relaxing and contracting // FASEB J. 1989. - Vol. 3. - P. 2007-2018.
Gilbert J.S., Niland M.J., Knoblich P. Placental ischemia and cardiovascular dysfunction in preeclampsia and beyond: making the connections. // Expert Rev. Cardiovasc. Ther. - 6 (10). - 2008. P. 1367-1377.
Ignarro L. J. Experimental evidences of nitric oxidedependent vasodilatory activity of nebivolol, a third-generation beta-blocker. // Blood Press Suppl. - 1. - 2004. P. 2-16.
Neri I., Jasonni V.M., Gori G.F., etal. Efect of L-arginine on blood pressure in pregnancy-induced hypertension: a randomized placebo-controlled trial.//J. Matern. Fetal Neonatal. Med. - 19 (5). - 2006. P. 277-281.
Rytlewski K., Olszanecki R., Lauterbach R., etal. Efects of oral L-arginine on the fetal condition and neonatal outcome in
preeclampsia: a preliminary report. // Basic Clin. Pharmacol. Toxicol. - 99 (2). - 2006. P. 146-152.
Roberts J.M., Pearson G., Cutler J. etal. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy/J.M. Roberts, // Hypertension. - 2003. - Vol. 41 (3). - P. 437-445.
Rubinshtein R, Kuvin JT, Soffler M, etal. Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. // Eur Heart J. - 2010. - May;31(9). - P.1142-8
Sieroszewski P., Suzin J., Karowicz-Bilihska A Ultrasound evaluation of intrauterine growth restriction therapy by a nitric oxide donor (L-arginine).//J. Matern. Fetal. Neonatal. Med. - 2004. - 15 (6). - P. 363-366.
Zanchetti A. Clinical pharmacodynamics of nebivolol: new evidence of nitric oxide-mediated vasodilating activity and peculiar haemodynamic properties in hypertensive patients. // Blood Pressure. - 2004. - 13 (Suppl 1). P. 18-33.
Zhang N., Xiong AH., Xiao X., Li L.P. Effect and mechanism of L-arginine therapy for fetal growth retardation due to pregnancy-induced hypertension. Nan. Fang Yi Ke Da Xue Xue Bao . - 2007. - 27 (2). - P. 198-200.
Downloads
How to Cite
Issue
Section
License
Authors who publish in this journal agree to the following terms:
1. The authors reserve the right to authorship of the work and pass the journal right of first publication of this work is licensed under a Creative Commons Attribution License, which allows others to freely distribute the work published with reference to the authors of the original work and the first publication of this magazine.
2. Authors are entitled to enter into a separate agreement on additional non-exclusive distribution of work in the form in which it was published in the magazine (eg work place in the electronic repository institution or publish monographs in part), provided that the reference to the first publication of this magazine.
3. Policy magazine allows and encourages authors placement on the Internet (eg, in storage facilities or on personal websites) manuscript of how to submit the manuscript to the editor and during his editorial processing, since it contributes to productive scientific discussion and positive impact on the efficiency and dynamics of citing published work (see. The Effect of Open Access).
